Equine airway disorders

US9352152B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9352152-B2
Application numberUS-96266707-A
CountryUS
Kind codeB2
Filing dateDec 21, 2007
Priority dateDec 22, 2006
Publication dateMay 31, 2016
Grant dateMay 31, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Airway disorders in a horse are relieved by electrical stimulation of the airway tissue. Particular disorders and techniques include electrical stimulation to relieve laryngeal hemiplegia. A pacemaker processor generates an electrical treatment signal to be applied to upper airway tissue of the horse for treating the upper airway disorder. One or more stimulation electrodes interfaces with the upper airway tissue for delivering the treatment signal to the upper airway tissue.

First claim

Opening claim text (preview).

What is claimed is: 1. A device for treating laryngeal hemiplegia in horses, the device comprising: a pacemaker processor configured to generate an electrical signal to be applied to upper airway tissue of the horse and configured to cause complete and continuous abduction of the vocal fold during a period of minutes up to hours in order to treat the laryngeal hemiplegia; and one or more stimulation electrodes adapted to interface with the upper airway tissue for delivering the electrical signal to the upper airway tissue. 2. The device of claim 1 , wherein at least a portion of the device is implanted in the horse. 3. The device of claim 2 , wherein the implanted portion of the device communicates transcutaneously or percutaneously with a portion of the device located externally to the horse. 4. The device of claim 3 , wherein communication transcutaneously is based on at least one of electromagnetic induction, acoustic energy, optical energy, and capacitor coupling. 5. The device of claim 2 , wherein a portion of the device is configured to be placed temporarily on the surface of the horse when the device is operating to provide external signals to the implanted portion of the device. 6. The device of claim 2 , wherein the implanted portion includes a power source which is charged percutaneously or transcutaneously. 7. The device of claim 1 , wherein the electrical signal is derived from at least one of an electromyogram, an electronystagmograph, an electroglottograph, an electroencephalograph, a biopotential sensor, an ultrasound sensor, a hall sensor, a microphone, a pressure sensor, a strain transducer, a mechanical deformation sensor, and a motion sensor. 8. The device of claim 1 , wherein the electrical signal is applied to the upper airway tissue of the horse using a biphasic waveform. 9. The device of claim 1 , wherein the one or more stimulation electrodes are based on at least one of a cuff electrode, a multipolar cuff electrode, a tripolar cuff electrode, a flat nerve electrode, an epineural electrode, a shaft electrode, a longitudinal intrafascicular electrode, a thin wire electrode, a micro-machined electrode, a sieve electrode, and a staple electrode. 10. The device of claim 1 , wherein the upper airway tissue includes one or more nerves of an airway structure. 11. The device of claim 10 , wherein the one or more nerves includes the recurrent laryngeal nerve of the horse. 12. The device claim 11 , wherein the upper airway tissue includes one or more axons of the abductor branch of the recurrent laryngeal nerve. 13. The device of claim 1 , further comprising one or more treatment sensors configured to sense at least one therapy parameter related to the horse, wherein the at least one therapy parameter relates to at least one of air flow characteristics of the airway tract of a horse, contractile characteristics of the airway tissue of a horse, electrical characteristics of a portion of the body of the horse, temperature of a portion of the body of the horse, pH of a portion of the body of the horse, chemical constituency of a portion of the body of the horse, and physiological state of the horse. 14. The device of claim 1 , further comprising one or more treatment sensors configured to sense at least one therapy parameter related to the pacemaker processor, the one or more stimulation electrodes, or both. 15. A device for treating laryngeal hemiplegia in horses, the device comprising: a pacemaker processor configured to generate an electrical signal to be applied to upper airway tissue of the horse and configured to cause continuous abduction of the vocal fold during a period of minutes up to hours in order to treat the laryngeal hemiplegia; one or more stimulation electrodes adapted to interface with the upper airway tissue for delivering the electrical signal to the upper airway tissue; one or more treatment sensors configured to sense at least one therapy parameter related to the horse; and a treatment verification monitor configured to monitor the electrical signal delivered by the one or more stimulation electrodes and to monitor an effect of the at least one therapy parameter on the horse before, during, or after an athletic performance. 16. The device of claim 15 , further comprising: a record log for recording the at least one therapy parameter. 17. The device of claim 15 , wherein the treatment verification monitor produces an external signal when the pacemaker processor is operating. 18. The device of claim 17 wherein the external signal includes a visible movement of a muscle of the horse accomplished by stimulating the muscle with an electrode. 19. A treatment verification system for verifying proper treatment of laryngeal hemiplegia in a horse, the system comprising: a pacemaker processor configured to generate an electrical signal to be applied to upper airway tissue of the horse and configured to cause vocal fold abduction continuously during a period of minutes up to hours in order to treat the laryngeal hemiplegia; one or more stimulation electrodes adapted to interface with upper airway tissue of the horse for delivering the electrical signal to the upper airway tissue of the horse; and a treatment verification monitor configured to monitor the electrical signal delivered by the one or more stimulation electrodes and to monitor an effect of at least one therapy parameter on the horse before, during, or after an athletic performance. 20. The system of claim 19 , further comprising one or more treatment sensors configured to sense the at least one therapy parameter related to operation of the treatment verification system.

Assignees

Inventors

Classifications

  • Paddle shaped electrodes, e.g. for laminotomy · CPC title

  • Anchoring or fixation means therefor · CPC title

  • Measuring impedance of respiratory organs or lung elasticity · CPC title

  • Skin piercing electrodes · CPC title

  • Human Necessities · mapped topic

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9352152B2 cover?
Airway disorders in a horse are relieved by electrical stimulation of the airway tissue. Particular disorders and techniques include electrical stimulation to relieve laryngeal hemiplegia. A pacemaker processor generates an electrical treatment signal to be applied to upper airway tissue of the horse for treating the upper airway disorder. One or more stimulation electrodes interfaces with the …
Who is the assignee on this patent?
Lindenthaler Werner, Sanders Ira, Ducharme Norm G, and 2 more
What technology area does this patent fall under?
Primary CPC classification A61N1/3601. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue May 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).